Second Cancer Incidence and Cause‐Specific Mortality in Primary Gastrointestinal Non‐Hodgkin Lymphoma Survivors: A Population‐Based Cohort Study
PGI-NHL survivors face elevated long-term SPC risk, particularly after chemoradiotherapy and in younger patients. Excess risks for both SPCs and mortality persist beyond two decades, necessitating lifelong, risk-adapted survivorship care that includes cancer surveillance, infection prevention, and chronic comorbidity management.
Authors
- Liangshun You (ORCID: https://orcid.org/0000-0003-4575-3287)
- Yifu Ding (ORCID: https://orcid.org/0000-0002-4629-5858)
- Feng Zhao (ORCID: https://orcid.org/0000-0002-4441-9992)
- Jianping Yang (ORCID: https://orcid.org/0000-0001-5336-6530)
- Jiahe Wu (ORCID: https://orcid.org/0000-0003-0080-6859)
- Jili Wang (ORCID: https://orcid.org/0000-0002-8976-508X)
- Xiaofei Cheng
Institutions
- Zhejiang Cancer Hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Hangzhou Medical College (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/cam4.71405
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China